American Bio Medica Corporation
ABMC
$0.0001
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 164.00K | 167.00K | 209.00K | 185.00K | 351.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 164.00K | 167.00K | 209.00K | 185.00K | 351.00K |
| Cost of Revenue | 90.00K | 307.00K | 218.00K | 258.00K | 323.00K |
| Gross Profit | 74.00K | -140.00K | -9.00K | -73.00K | 28.00K |
| SG&A Expenses | 258.00K | 230.00K | 231.00K | 256.00K | 337.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 376.00K | 559.00K | 471.00K | 532.00K | 682.00K |
| Operating Income | -212.00K | -392.00K | -262.00K | -347.00K | -331.00K |
| Income Before Tax | 1.88M | -317.00K | -314.00K | -398.00K | -379.00K |
| Income Tax Expenses | -- | 0.00 | -- | 2.00K | -- |
| Earnings from Continuing Operations | 1.88M | -317.00K | -314.00K | -400.00K | -379.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.88M | -317.00K | -314.00K | -400.00K | -379.00K |
| EBIT | -212.00K | -392.00K | -262.00K | -347.00K | -331.00K |
| EBITDA | -204.00K | -379.00K | -250.00K | -334.00K | -318.00K |
| EPS Basic | 0.04 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.04 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 48.10M | 48.10M | 48.10M | 48.10M | 47.77M |
| Average Diluted Shares Outstanding | 48.10M | 48.10M | 48.10M | 48.10M | 47.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
